0
1
interesting
-
1
8/6/22 at 8:42am
Organization
Nature.com
32 words
0
Comments
Silencing of the retinal clock through targeting neuronal Bmal1 could constitute an approach to treating some forms of retinopathy.
You are the first to view
https://www.nature.com/articles/s42003-022-03774-2
Create an account
or login to join the discussion